We are live on ! Find out more
PA

Perceptive Advisors Portfolio holdings

AUM $6.66B
1-Year Est. Return 360.84%
This Fund
S&P 500
This Quarter Est. Return
-7.79%
1 Year Est. Return
+360.84%
3 Year Est. Return
+1,707.27%
5 Year Est. Return
+3,210.42%
10 Year Est. Return
+53,055.89%
AUM
$1.41B
AUM Growth
-$143M
Cap. Flow
+$78.9M
Cap. Flow %
5.61%
Top 10 Hldgs %
48.2%
Holding
246
New
54
Increased
32
Reduced
53
Closed
52

Top Buys

Rank Stock Value
1
NBIX icon
Neurocrine Biosciences
NBIX
+$38M
2
FOLD
Amicus Therapeutics
FOLD
+$22M
3
ACRS icon
Aclaris Therapeutics
ACRS
+$21.2M
4
LKFT
Lakefront Biotherapeutics American Depositary Shares
LKFT
+$18.7M
5
ANIP icon
ANI Pharmaceuticals
ANIP
+$15.6M

Top Sells

Rank Stock Value
1
SRPT icon
Sarepta Therapeutics
SRPT
+$25.1M
2
DXCM icon
DexCom
DXCM
+$15.7M
3
AERI
Aerie Pharmaceuticals
AERI
+$13.5M
4
ASRT
Assertio
ASRT
+$13.4M
5
CRBP icon
Corbus Pharmaceuticals
CRBP
+$11.1M

Sector Composition

Rank Sector Weight
1 Healthcare 97.84%
2 Miscellaneous 1.6%
3 Consumer Staples 0.43%
4 Consumer Discretionary 0.07%
5 Industrials 0.05%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MD icon
201
Pediatrix Medical
MD
$2.12B
– –
-29
Closed -$2K
MTD icon
202
Mettler-Toledo International
MTD
$27.6B
– –
-415
Closed -$174K
PAHC icon
203
Phibro Animal Health
PAHC
$1.43B
– –
-24,300
Closed -$660K
STRR
204
DELISTED
Star Equity Holdings
STRR
– –
-500
Closed -$127K
TDOC icon
205
Teladoc Health
TDOC
$1.17B
– –
-15,000
Closed -$275K
THC icon
206
Tenet Healthcare
THC
$21.4B
– –
-16,200
Closed -$367K
TMO icon
207
Thermo Fisher Scientific
TMO
$240B
$0 ﹤0.01%
+2
New +$295
UHS icon
208
Universal Health Services
UHS
$10.7B
– –
-3,989
Closed -$492K
VTRS icon
209
Viatris
VTRS
$19.5B
– –
-94,711
Closed -$3.61M
ZTS icon
210
Zoetis
ZTS
$30.2B
$0 ﹤0.01%
+3
New +$153
ONC
211
BeOne Medicines Ltd
ONC
$39.4B
– –
-132,057
Closed -$4.07M
NVRO
212
DELISTED
NEVRO CORP.
NVRO
– –
-11,746
Closed -$1.23M
CTLT
213
DELISTED
CATALENT, INC.
CTLT
$0 ﹤0.01%
+3
New +$74
KA
214
DELISTED
Kineta, Inc. Common Stock
KA
– –
-2,461
Closed -$5.37M
NSTG
215
DELISTED
NanoString Technologies, Inc.
NSTG
– –
-10,518
Closed -$210K
NUVA
216
DELISTED
NuVasive, Inc.
NUVA
– –
-2,589
Closed -$173K
LCI
217
DELISTED
Lannett Company, Inc.
LCI
– –
-6,668
Closed -$709K
IVC
218
DELISTED
Invacare Corporation
IVC
– –
-13,200
Closed -$147K
HNGR
219
DELISTED
Hanger Inc.
HNGR
– –
-15,038
Closed -$128K
TVTY
220
DELISTED
Tivity Health, Inc. Common Stock
TVTY
– –
-21,608
Closed -$572K
VCRA
221
DELISTED
VOCERA COMMUNICATIONS, INC.
VCRA
– –
-94,236
Closed -$1.59M
IMMU
222
DELISTED
Immunomedics Inc
IMMU
– –
-5,343
Closed -$17K
MNK
223
DELISTED
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
– –
-4,500
Closed -$314K
ACHN
224
DELISTED
Achillion Pharmaceuticals
ACHN
– –
-929,290
Closed -$7.53M
MDSO
225
DELISTED
Medidata Solutions, Inc.
MDSO
– –
-2,865
Closed -$160K
6 7 8
9
10

Similar funds

QP
Quilter Plc London, United Kingdom $6.65B AUM 37.83% 1-Year Est. Return
FCBT
First Citizens Bank & Trust Raleigh, North Carolina $6.69B AUM 24.48% 1-Year Est. Return
RWM
Ritholtz Wealth Management New York $6.7B AUM 32.7% 1-Year Est. Return
AWA
Arkadios Wealth Advisors Atlanta, Georgia $6.6B AUM 30.67% 1-Year Est. Return
WHRC
W.H. Reaves & Co Jersey City, New Jersey $6.59B AUM 31.9% 1-Year Est. Return
KGA
K5 Global Advisor Miami Beach, Florida $6.59B AUM
LSERS
Louisiana State Employees Retirement System Baton Rouge, Louisiana $6.74B AUM 53.06% 1-Year Est. Return
CAG
Crestwood Advisors Group Boston, Massachusetts $6.74B AUM 30.22% 1-Year Est. Return

Perceptive Advisors's Q4 2016 Portfolio in Review

As of Q4 2016, Perceptive Advisors held 246 positions worth $1.41B, down 9.2% from $1.55B the previous quarter. Its ten largest holdings account for 48% of the portfolio.

Perceptive Advisors deployed $78.9M of net new capital in Q4 2016, opening 54 new positions and adding to 32 existing holdings. Its largest new stake was Lakefront Biotherapeutics American Depositary Shares: 304,531 shares worth $20.6M.

By sector, the portfolio is most concentrated in Healthcare at 98% of assets, up from 97% a quarter earlier, followed by Miscellaneous and Consumer Staples.

On the sell side, the largest reduction was Sarepta Therapeutics, an estimated $25.1M trimmed.

  • Perceptive Advisors's largest Q4 2016 buy was Lakefront Biotherapeutics American Depositary Shares: 304,531 shares worth $20.6M.
  • Perceptive Advisors added most to Neurocrine Biosciences in Q4 2016, an estimated $38M increase.
  • Perceptive Advisors's biggest Q4 2016 reduction was Sarepta Therapeutics, cutting an estimated $25.1M.
  • Perceptive Advisors fully exited DexCom in Q4 2016, selling an estimated $15.7M.
  • Perceptive Advisors's ten largest holdings make up 48% of its $1.41B portfolio in Q4 2016.
  • Perceptive Advisors opened 54 new positions and closed 52 in Q4 2016.
  • Perceptive Advisors's portfolio value fell 9.2% quarter-over-quarter to $1.41B.

Based on Perceptive Advisors's 13F filing for Q4 2016, filed 14 Feb 2017.